190 related articles for article (PubMed ID: 9823323)
21. Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids.
Leslie EM; Mao Q; Oleschuk CJ; Deeley RG; Cole SP
Mol Pharmacol; 2001 May; 59(5):1171-80. PubMed ID: 11306701
[TBL] [Abstract][Full Text] [Related]
22. Doxorubicin- and daunorubicin-glutathione conjugates, but not unconjugated drugs, competitively inhibit leukotriene C4 transport mediated by MRP/GS-X pump.
Priebe W; Krawczyk M; Kuo MT; Yamane Y; Savaraj N; Ishikawa T
Biochem Biophys Res Commun; 1998 Jun; 247(3):859-63. PubMed ID: 9647783
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.
Müller M; Meijer C; Zaman GJ; Borst P; Scheper RJ; Mulder NH; de Vries EG; Jansen PL
Proc Natl Acad Sci U S A; 1994 Dec; 91(26):13033-7. PubMed ID: 7809167
[TBL] [Abstract][Full Text] [Related]
24. Multifactorial involvement of multidrug resistance-associated [correction of resistance] protein, DNA topoisomerase II and glutathione/glutathione-S-transferase in nonP-glycoprotein-mediated multidrug resistance in human bladder cancer cells.
Kim WJ; Kakehi Y; Yoshida O
Int J Urol; 1997 Nov; 4(6):583-90. PubMed ID: 9477189
[TBL] [Abstract][Full Text] [Related]
25. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein.
Zaman GJ; Lankelma J; van Tellingen O; Beijnen J; Dekker H; Paulusma C; Oude Elferink RP; Baas F; Borst P
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7690-4. PubMed ID: 7644478
[TBL] [Abstract][Full Text] [Related]
26. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein.
Draper MP; Martell RL; Levy SB
Br J Cancer; 1997; 75(6):810-5. PubMed ID: 9062400
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity studies of verapamil analogs that modulate transport of leukotriene C(4) and reduced glutathione by multidrug resistance protein MRP1.
Loe DW; Oleschuk CJ; Deeley RG; Cole SP
Biochem Biophys Res Commun; 2000 Sep; 275(3):795-803. PubMed ID: 10973801
[TBL] [Abstract][Full Text] [Related]
28. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates.
Leier I; Jedlitschky G; Buchholz U; Cole SP; Deeley RG; Keppler D
J Biol Chem; 1994 Nov; 269(45):27807-10. PubMed ID: 7961706
[TBL] [Abstract][Full Text] [Related]
29. Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3).
Grant CE; Gao M; DeGorter MK; Cole SP; Deeley RG
Drug Metab Dispos; 2008 Dec; 36(12):2571-81. PubMed ID: 18775981
[TBL] [Abstract][Full Text] [Related]
30. Rapid recovery of a functional MDR phenotype caused by MRP after a transient exposure to MDR drugs in a revertant human lung cancer cell line.
Gonzalez Manzano R; Versanvoort C; Wright K; Twentyman PR
Eur J Cancer; 1996 Nov; 32A(12):2136-41. PubMed ID: 9014757
[TBL] [Abstract][Full Text] [Related]
31. Effect of glucose transport inhibitors on vincristine efflux in multidrug-resistant murine erythroleukaemia cells overexpressing the multidrug resistance-associated protein (MRP) and two glucose transport proteins, GLUT1 and GLUT3.
Martell RL; Slapak CA; Levy SB
Br J Cancer; 1997; 75(2):161-8. PubMed ID: 9010020
[TBL] [Abstract][Full Text] [Related]
32. Increased sensitivity to vincristine of MDR cells by the leukotriene D4 receptor antagonist, ONO-1078.
Nagayama S; Chen ZS; Kitazono M; Takebayashi Y; Niwa K; Yamada K; Tani A; Haraguchi M; Sumizawa T; Furukawa T; Aikou T; Akiyama S
Cancer Lett; 1998 Aug; 130(1-2):175-82. PubMed ID: 9751271
[TBL] [Abstract][Full Text] [Related]
33. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP.
Cole SP; Deeley RG
Bioessays; 1998 Nov; 20(11):931-40. PubMed ID: 9872059
[TBL] [Abstract][Full Text] [Related]
34. Characterisation of multidrug-resistant Ehrlich ascites tumour cells selected in vivo for resistance to etoposide.
Nielsen D; Maare C; Eriksen J; Litman T; Friche E; Skovsgaard T
Biochem Pharmacol; 2000 Aug; 60(3):353-61. PubMed ID: 10856430
[TBL] [Abstract][Full Text] [Related]
35. Identification of an amino acid residue in multidrug resistance protein 1 critical for conferring resistance to anthracyclines.
Zhang DW; Cole SP; Deeley RG
J Biol Chem; 2001 Apr; 276(16):13231-9. PubMed ID: 11278596
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the ATP-dependent LTC4 transporter in cisplatin-resistant human KB cells.
Chuman Y; Chen ZS; Sumizawa T; Furukawa T; Haraguchi M; Takebayashi Y; Niwa K; Yamada K; Aikou T; Akiyama S
Biochem Biophys Res Commun; 1996 Sep; 226(1):158-65. PubMed ID: 8806607
[TBL] [Abstract][Full Text] [Related]
37. Bioflavonoid stimulation of glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1).
Leslie EM; Deeley RG; Cole SP
Drug Metab Dispos; 2003 Jan; 31(1):11-5. PubMed ID: 12485947
[TBL] [Abstract][Full Text] [Related]
38. Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP.
Germann UA; Ford PJ; Shlyakhter D; Mason VS; Harding MW
Anticancer Drugs; 1997 Feb; 8(2):141-55. PubMed ID: 9073310
[TBL] [Abstract][Full Text] [Related]
39. Transport properties of the multidrug resistance-associated protein (MRP) in human tumour cells.
Holló Z; Homolya L; Hegedüs T; Sarkadi B
FEBS Lett; 1996 Mar; 383(1-2):99-104. PubMed ID: 8612802
[TBL] [Abstract][Full Text] [Related]
40. Multidrug resistance-associated protein: a protein distinct from P-glycoprotein involved in cytotoxic drug expulsion.
Barrand MA; Bagrij T; Neo SY
Gen Pharmacol; 1997 May; 28(5):639-45. PubMed ID: 9184795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
